Table 2.
Targets identified by integrative approach and validation
| Gene | Abbreviation | Location | CGH Loss % | Median Tumor Expression vs Nevi |
Aza Fold Upregulation |
|---|---|---|---|---|---|
| Chordin-like 1 | CHRDL1 | Xq23 | −13.2 | 0.15 | 1.70 |
| Secreted frizzled-related protein 1 | SFRP1 | 8p12 | −12.3 | 0.17 | 1.72 |
| Transmembrane protein 47 | TMEM47 | Xp11 | −13.5 | 0.08 | 1.29 |
| Transcription factor 8 | ZEB1 | 10p11 | −20.8 | 0.33 | 1.85 |
| Lipoprotein lipase | LPL | 8p22 | −13.2 | 0.32 | 1.28 |
| Retinoic acid receptor responder 1 | RARRES1 | 3q25 | −19.8 | 0.46 | 1.74 |
| Phosphatidylinositol-specific phospholipase C, X domain containing 1 |
PLCXD1 | Xp22 | −16 | 0.41 | 1.32 |
| Zinc finger protein 22 | KOX 15 | 10q11 | −24.5 | 0.43 | 1.29 |